A 4-part, Single-dose, Open-label, Randomised, Crossover, Exploratory Study in Healthy Subjects to Assess the Influence of an Opioid Antagonist on How the Body Processes a Strong Painkiller, When Co-administered in a Fasted and Fed State.
Phase of Trial: Phase I
Latest Information Update: 31 Jul 2014
Price : $35 *
At a glance
- Drugs MR XXX (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Mundipharma Research
- 26 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 22 May 2014 New trial record